Static Chart Toleranzia AB

Equities

Delayed Nasdaq Stockholm Other stock markets 05:45:45 11/06/2024 pm IST			5-day change	1st Jan Change
0.63 ^SEK	-8.70%		-4.26%	+47.20%

31/05	Toleranzia AB Conducts Successful Safety Study of TOL2 in Blood Samples from Patients with Myasthenia gravis	CI
20/05	Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Duration

Period